BML Investment Partners, L.P. 13D and 13G filings for ARCA biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 1:08 pm Sale |
2023-12-31 | 13G | ARCA biopharma, Inc. ABIO |
BML Investment Partners, L.P. | 58,911 4.900% |
-12,611 (-17.63%) |
Filing |
| 2023-02-08 2:48 pm Purchase |
2023-02-08 | 13G | ARCA biopharma, Inc. ABIO |
BML Investment Partners, L.P. | 71,521 5.950% |
8,033 (+12.65%) |
Filing |
| 2022-01-27 3:53 pm Purchase |
2022-01-24 | 13G | ARCA biopharma, Inc. ABIO |
BML Investment Partners, L.P. | 63,488 5.300% |
63,488 (New Position) |
Filing |